| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/11/2006 | US20060099625 MT-SP1 serine protease |
| 05/11/2006 | US20060099600 Novel acetylcholine transporter |
| 05/11/2006 | US20060099579 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099220 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 05/11/2006 | US20060099217 Inhibiting MHC class I antigen processing by ER aminopeptidase by administering an aminopeptidase inhibitor that is leucine-thiol, lysine-thiol, isoleucine-thiol, bis(1-thio-2-amino-4-methylpentane) diHCL, bis(1-thio-2-amino-3-phenylpropane) diHCL, or an alpha-thiolbestatin and confirming inhibition |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099214 Cancer-linked gene as target for chemotherapy |
| 05/11/2006 | US20060099213 Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 05/11/2006 | US20060099212 treating or preventing a tumor necrosis factor-mediated disease by co-administering methotrexate and a TNF alpha antagonist |
| 05/11/2006 | US20060099211 Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease |
| 05/11/2006 | US20060099210 for screening for modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression; polypeptides; polynucleotides; vectors; host cells |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099207 High affinity antibodies against HMGB1 and methods of use thereof |
| 05/11/2006 | US20060099206 Expression vector comprising gene constructs with deleted sequences; ehnancing heterologous gene expression |
| 05/11/2006 | US20060099205 Bispecific single chain FV antibody molecules and methods of use thereof |
| 05/11/2006 | US20060099204 humanizing a rabbit antibody; to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody |
| 05/11/2006 | US20060099203 B7-DC binding antibody |
| 05/11/2006 | US20060099202 Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor response |
| 05/11/2006 | US20060099201 Treating a mammal with a formulation comprising an antibody which binds IgE |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | CA2586844A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 05/11/2006 | CA2586491A1 Atazanavir conjugates and antibodies useful in immunoassay |
| 05/11/2006 | CA2586067A1 Immunoglobulin fractions |
| 05/11/2006 | CA2585849A1 Use of cr1-binding molecules in clearance and induction of immune responses |
| 05/11/2006 | CA2585574A1 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 05/11/2006 | CA2581300A1 Composition comprising vlp and amyloid-beta peptide |
| 05/11/2006 | CA2566535A1 Ige-retargeting, function-altering molecules (erfam) for treatment of allergic diseases |
| 05/10/2006 | EP1655607A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 05/10/2006 | EP1655605A2 Treatment and diagnosis of cancer |
| 05/10/2006 | EP1655371A1 System for the production of dimeric proteins based on the transport system of hemolysin of escherichia coli |
| 05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655307A1 Atopic dermatitis inducer |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 05/10/2006 | EP1654377A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 05/10/2006 | EP1654370A2 Accelerated vaccination |
| 05/10/2006 | EP1654358A1 Binding constructs and methods for use thereof |
| 05/10/2006 | EP1654287A2 Cd20-binding polypeptide compositions |
| 05/10/2006 | EP1654286A1 Humanized anti-cd4 antibody with immunosuppressive properties |
| 05/10/2006 | EP1654000A1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 05/10/2006 | EP1653999A1 Compositions and methods for manipulating levels antigen-specific antibodies in a mammal |
| 05/10/2006 | EP1653986A2 Treatment of cancers expressing p95 erbb2 |
| 05/10/2006 | EP1653915A2 Prkcs as modifiers of the beta catenin pathway and methods of use |
| 05/10/2006 | EP1653844A2 Prion-specific peptide reagents |
| 05/10/2006 | EP1653801A2 Altered antibodies having improved antigen-binding affinity |
| 05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
| 05/10/2006 | EP1392859B1 Isolating cells expressing secreted proteins |
| 05/10/2006 | EP1307569B1 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
| 05/10/2006 | EP1265631B1 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1185297B1 Streptococcus pneumoniae proteins and vaccines |
| 05/10/2006 | EP0990001B1 Processes for production of immunoglobulin a in milk |
| 05/10/2006 | EP0721505B2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/10/2006 | CN1771338A High affinity anti-human IgE antibodies |
| 05/10/2006 | CN1771329A The use of PDE4D in the screening for medicaments against atherosclerosis |
| 05/10/2006 | CN1771261A Antibodies against insulin-like growth factor I receptor and thereof |
| 05/10/2006 | CN1771260A Protein a chromatography |
| 05/10/2006 | CN1771056A Severe acute respiratory syndrome associated antibodies and method for detecting them and use thereof |
| 05/10/2006 | CN1771053A Immunoglobulin formulation and method of preparation thereof |
| 05/10/2006 | CN1771052A Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 05/10/2006 | CN1769296A Candida albicans gene CaTHI13,coded protein and its uses |
| 05/10/2006 | CN1769295A Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 05/10/2006 | CN1768861A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255539C Pesticidal proteins and strains |
| 05/10/2006 | CN1255537C Variable region gene of high neutralization activity monoclonal antibody of tumor necrosis factor and its preparation |
| 05/10/2006 | CN1255536C Variable region gene of high affinity monoclonal antibody of tumor necrosis factor and its preparation |
| 05/09/2006 | US7041870 Transgenic mammal for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders |
| 05/09/2006 | US7041855 High activity pegylated protein conjugates; reduced immunogenicity; synthesis |
| 05/09/2006 | US7041807 Antibodies to a YYX epitope of a mammalian prion protein |
| 05/09/2006 | US7041806 Netrin receptors |
| 05/09/2006 | US7041805 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders |
| 05/09/2006 | US7041804 Antibodies to PRO1387 polypeptides |
| 05/09/2006 | US7041803 Galectin 11 |
| 05/09/2006 | US7041802 Peptidoglycan recognition proteins |
| 05/09/2006 | US7041801 anti-Del-1 antibodies for immunological assessment of Del-1 protein expression and Del-1 inhibition or stimulation functions; tumor markers; angiogenesis inhibitors |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041793 Fusion protein comprising a cellulose binding domain and a domain having a high binding affinity for another ligand. |
| 05/09/2006 | US7041789 RFRP-3 and DNA thereof |
| 05/09/2006 | US7041499 Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
| 05/09/2006 | US7041496 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF) |
| 05/09/2006 | US7041458 Methods and reagents for determining protein S |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041299 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041292 binds ErbB2, blocks ligand activation of an ErbB receptor more effectively than humanized monoclonal antibody huMAb4D5-8 and blocks by 50% or greater binding of monoclonal antibody 2C4 (ATCC HB12697) to ErbB2. |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041288 Antiinflammatory agents; antiallergens |